spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online 11 July 2007
doi: 10.1242/dev.002576


Development 134, 2913-2923 (2007)
Published by The Company of Biologists 2007


This Article
Right arrow Summary Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmidt, M.
Right arrow Articles by Ye, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmidt, M.
Right arrow Articles by Ye, W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

EGFL7 regulates the collective migration of endothelial cells by restricting their spatial distribution

Maike Schmidt1, Kim Paes2, Ann De Mazière3, Tanya Smyczek1, Stacey Yang1, Alane Gray4, Dorothy French5, Ian Kasman5, Judith Klumperman3, Dennis S. Rice2 and Weilan Ye1,*

1 Tumor Biology and Angiogenesis Department, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA.
2 Lexicon Genetics Inc., 8800 Technology Forest Place, The Woodlands, TX 77381-1160, USA.
3 Cell Microscopy Center, Department of Cell Biology, University Medical Center Utrecht and Institute for Biomembranes, 3584CX, Utrecht, Netherlands.
4 Translational Oncology Department, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA.
5 Pathology Department, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA.


Figure 1
View larger version (116K):
[in this window]
[in a new window]

 
Fig. 1. General phenotypes of the Egfl7-knockout mouse. (A,B) Egfl7+/- (A) and Egfl7-/- (B) E14.5 littermates. Arrowhead indicates systemic oedema in the Egfl7-/- mouse. (C,D) CD31 [also known as PECAM1; brown, endothelial cell (EC) marker] and Hematoxylin (blue, H, nuclear marker) staining on transverse sections of the neck dermis from Egfl7+/+ (C) and Egfl7-/- (D) E14.5 littermates. Red bars indicate the thickness of the epidermis. Increased thickness in the Egfl7-/- tissue is a hallmark of oedema. (E) Body weights of multiple pairs of Egfl7+/+ and Egfl7-/- littermates at the indicated ages. Adults are all between 4-7 months. P values are calculated with unpaired, two-tailed t-test with 95% confidence interval (the same method is used for all P values unless specified otherwise). (F-M) Hypoxyprobe (brown) and Hematoxylin (blue) staining on sections of adult organs from Egfl7+/+ and Egfl7-/- littermates. Genotype and organ names are indicated. Arrowheads indicate example hypoxic cells. The actual size represented by the width of the panel: 8.5 mm (A,B); 0.87 mm (C,D); 430 µm (F-M).

 

Figure 2
View larger version (77K):
[in this window]
[in a new window]

 
Fig. 2. Loss of Egfl7 results in delay of vascularization. (A-D) CD31 wholemount staining on embryonic mouse hearts from Egfl7+/+ (A,B) and Egfl7-/- (C,D) littermates at E12.5 (A,C, dorsal view of the left ventricles) and E14.5 (B,D, lateral view of the left ventricles, dorsal is to the right). Asterisks, areas without coronary vasculature; weak signal is from the underlying endocardium. (E,F) CD31 wholemount staining on embryonic heads from Egfl7+/+ (E) and Egfl7-/- (F) littermates at E10.5. Open arrowheads, major cranial vessels. (G) Ventral coronary vascular coverage of multiple pairs of Egfl7+/+ and Egfl7-/- littermates at E12.5 and E14.5. Horizontal bars represent means. Because of large inter-litter variation at E12.5, littermate relationship is specified with numbers in the graph. Significant difference is marked with an asterisk next to each P value. (H) Major cranial vessel counts of multiple pairs of Egfl7+/+ and Egfl7-/- E10.5 littermates from two knockout lines. ins, insertional knockout line; hom, homologous recombination knockout line. (I-N) Isolectin B4 (EC marker) staining on flatmount neonatal retinas from Egfl7+/+ (I-K) and Egfl7-/- (L-N) littermates at P2 (I,L), P5 (J,M) and P8 (K,N). (O,P) Retinal vascular coverage (O) and size (P) of multiple pairs of Egfl7+/+ and Egfl7-/- newborn littermates at the indicated ages. Solid red arrowheads indicate example aberrant EC clusters; arrows indicate sprouts at the retinal vascular migration front. The actual size represented by the width of the panel: 0.9 mm (A,C); 1.4 mm (B,D); 3.6 mm (E,F); 3 mm (I,J,L,M); 4.7 mm (K,N); K and N are assembled from overlapping 4x images.

 

Figure 3
View larger version (118K):
[in this window]
[in a new window]

 
Fig. 3. Vascular phenotypes in the adult Egfl7-knockout mouse. (A-H) Fluorescent angiography (A-D) and CD31 fluorescent staining (E-H) in the retinas of multiple pairs of Egfl7+/+ (A,B,E,F) and Egfl7-/- (C,D,G,H) littermates. (I-L) High-magnification views of aberrant structures in the Egfl7-/- retinas. L is a z-section showing two juxtaposed vessels. Blue, DAPI (I-L, nuclear marker); green, CD31 (I-L); red, collagen IV (K,L only, vascular basement membrane marker). (M-P) CD31 staining on 50 µm-thick sections of peritonea (M,N) and kidney (O,P) from Egfl7+/+ (M,O) and Egfl7-/- (N,P) littermates. Arrowhead, tortuous vessels; red arrows, knots formed by multiple vessels; yellow arrows, vessels of similar diameter running close to each other; asterisks, vascular lumen. The actual size represented by the width of the panel: 1.2 mm (A-D); 330 µm (E-H); 88 µm (I-K); 25 µm (L); 275 µm (M-P).

 

Figure 4
View larger version (68K):
[in this window]
[in a new window]

 
Fig. 4. EGFL7 regulates the collective migration of ECs, but not the movement of individual ECs. (A,B) Live imaging at days 4-7 of cultured mouse aortic rings isolated from Egfl7+/+ (A) and Egfl7-/- (B) littermates. Colored arrowheads track individual sprouts over time. (C,D) Quantification of sprout length (C) and sprout extension velocity (D) on cultured aortic rings isolated from the Egfl7+/+ (blue bars) and Egfl7-/- (red bars) littermates. (E) Transwell migration assay performed on fibronectin- or EGFL7-coated inserts using ECs isolated from four pairs Egfl7+/+ and Egfl7-/- littermates. Migration efficiency was compared between Egfl7-/- (ko) and Egfl7+/+ (wt) samples and the ratios plotted. (F) Migration velocity of individual HUVECs on fibronectin (FN), EGFL7, or combined substrate. The actual size represented by the width of the panel: 1.09 mm (A); 0.73 mm (B).

 

Figure 5
View larger version (72K):
[in this window]
[in a new window]

 
Fig. 5. EGFL7 restricts the spatial distribution of migrating ECs. (A-F) Confocal images of vascular sprouts in P5 retinas from Egfl7+/+ (A-C) and Egfl7-/- (D-F) littermates stained with Isolectin B4 (white in A,D; green in B,C,E,F) and propidium iodide (PI) to indicate nuclei (red in B,C,E-F). C and F are z-sections of the retinal vascular migration front. These images were taken from areas similar to those indicated by the arrows and arrowheads in Fig. 2J,M. Crosses mark stalk cell nuclei; asterisks mark tip cell nuclei. (G,H) Tip (G) and stalk (H) cell counts in multiple 40 µm-long segments of sprouts from both genotypes. (I-L) Aortic rings isolated from Egfl7+/+ (I,J) and Egfl7-/- (K,L) littermates stained for CD31 (green) and with DAPI (red, pseudo color). White dashed lines outline the edges of the aortic rings. The CD31- DAPI+ signals in J and L are nuclei of fibroblasts and smooth muscle cells that have migrated away from the aortic rings. (M) EC counts in multiple 50 µm-long segments of sprouts from both genotypes. The actual size represented by the width of the panel: 230 µm (A,D); 76 µm (B,E); 298 µm (C,F); 1.3 mm (I,K); 294 µm (J-L).

 

Figure 6
View larger version (83K):
[in this window]
[in a new window]

 
Fig. 6. Aberrant localization of basement membrane marker in the Egfl7-/- vessels. Neonatal mouse retinas (A-F) or aortic rings (G-L) isolated from the Egfl7+/+ (A-C,G-I) and Egfl7-/- (D-F,J-L) littermates stained for collagen IV (green), CD31 (red) and with DAPI (blue). Representative single-frame confocal images (A,B,D,E,G,H,J,K) and optical z-sections (C,F,I,L) are shown. Arrowheads, vascular sprouts similar to those shown at higher magnification in the panels beneath; arrows, mislocalized collagen IV between ECs within a single sprout; asterisks, individual ECs. In C and F, two separate z-sections are shown in each panel. The actual size represented by the width of the panel: 732 µm (A,D); 108 µm (B,E); 36 µm (C,F); 366 µm (G,J); 72 µm (H,I,K,L).

 

Figure 7
View larger version (64K):
[in this window]
[in a new window]

 
Fig. 7. EGFL7 is associated with the interstitial ECM. (A) Anti-HA western blot on different fractions of chicken embryonic fibroblasts expressing GFP or HA-tagged human EGFL7 (top panel), and Coomassie Blue staining of the same cell fractions prepared from an equal number of cells (bottom panel). (B-G) The following cells were cultured for 3 days and then double stained for EGFL7 (green) and with DAPI (blue) in the absence of detergent: HUVECs (dark blue ovals in diagram) and human dermal fibroblasts (light blue ovals) in mixed culture (B); HUVECs alone (C); fibroblasts alone (E); HUVECs in the bottom well with fibroblasts in an insert (D); or HUVEC alone on fibronectin (F) or laminin (G). (H-M) Confocal images of aortic ring sprouts from Egfl7+/+ (H-K) or Egfl7-/- (L,M) littermates stained for fibronectin (blue), EGFL7 (red), CD31 (green) and with DAPI (gray). H-J show a segment of sprout with stalk cells; K shows tip cells; L,M show a segment of sprouts with both tip and stalk cells. The actual size represented by the width of the panel: 650 µm (B-G); 80 µm (H-J); 54 µm (K); 100 µm (L,M).

 

Figure 8
View larger version (41K):
[in this window]
[in a new window]

 
Fig. 8. A model describing how EGFL7 regulates sprout morphology and motility.

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




© The Company of Biologists Ltd 2007